Patents by Inventor Kim Alving

Kim Alving has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for quantifying drug concentration in a prodrug composition
    Patent number: 11796546
    Abstract: Methods for quantifying the amount of drug present in a crosslinked hyaluronic acid-linker-peptide (xHA-L-P) prodrug composition are provided. Disclosed are steps of contacting a sample of the xHA-L-P prodrug formulation with a hyaluronoglucosidase to generate oligomeric hyaluronic acid-linker-peptide drug (oHA-L-P), contacting the oHA-L-P with a second enzyme to generate peptide digest products of the drug, and detecting the peptide digest products to determine the amount of the drug present in the xHA-L-P prodrug formulation.
    Type: Grant
    Filed: May 6, 2020
    Date of Patent: October 24, 2023
    Assignee: GENZYME CORPORATION
    Inventors: Kim Alving, Bing Wang
  • METHODS FOR CHARACTERIZING COMPOSITIONS COMPRISING PEANUT ANTIGENS
    Publication number: 20220170942
    Abstract: Methods for determining an in vitro release profile of peanut allergens in a sample are provided. Methods for determining one or more signatures of peanut allergens in a sample are provided.
    Type: Application
    Filed: November 10, 2021
    Publication date: June 2, 2022
    Inventors: Kim Alving, Pierre deMontigny, Bing Huang Wang
  • Methods for characterizing compositions comprising peanut antigens
    Patent number: 11199548
    Abstract: Methods for determining an in vitro release profile of peanut allergens in a sample are provided. Methods for determining one or more signatures of peanut allergens in a sample are provided.
    Type: Grant
    Filed: September 24, 2019
    Date of Patent: December 14, 2021
    Assignee: SANOFI
    Inventors: Kim Alving, Pierre deMontigny, Bing Huang Wang
  • METHODS FOR QUANTIFYING DRUG CONCENTRATION IN A PRODRUG COMPOSITION
    Publication number: 20200386768
    Abstract: Methods for quantifying the amount of drug present in a prodrug composition are provided.
    Type: Application
    Filed: May 6, 2020
    Publication date: December 10, 2020
    Inventors: Kim Alving, Bing Wang
  • METHODS FOR CHARACTERIZING COMPOSITIONS COMPRISING PEANUT ANTIGENS
    Publication number: 20200116732
    Abstract: Methods for determining an in vitro release profile of peanut allergens in a sample are provided. Methods for determining one or more signatures of peanut allergens in a sample are provided.
    Type: Application
    Filed: September 24, 2019
    Publication date: April 16, 2020
    Inventors: Kim Alving, Pierre deMontigny, Bing Huang Wang
  • Methods for characterizing compositions comprising peanut antigens
    Patent number: 10466250
    Abstract: Methods for determining an in vitro release profile of peanut allergens in a sample are provided. Methods for determining one or more signatures of peanut allergens in a sample are provided.
    Type: Grant
    Filed: December 28, 2016
    Date of Patent: November 5, 2019
    Assignee: SANOFI
    Inventors: Kim Alving, Pierre deMontigny, Bing Huang Wang
  • METHODS FOR CHARACTERIZING COMPOSITIONS COMPRISING PEANUT ANTIGENS
    Publication number: 20170219600
    Abstract: Methods for determining an in vitro release profile of peanut allergens in a sample are provided. Methods for determining one or more signatures of peanut allergens in a sample are provided.
    Type: Application
    Filed: December 28, 2016
    Publication date: August 3, 2017
    Inventors: Kim Alving, Pierre deMontigny, Bing Huang Wang
  • Pancreatic cancer secreted targets and uses thereof
    Publication number: 20080219992
    Abstract: The present invention provides a method for diagnosing and detecting diseases associated with pancreas. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in pancreatic diseases (PCAST) and antibodies binds to PCAST. The present invention provides that PCAST is used as targets for screening agents that modulates the PCAST activities. Further the present invention provides methods for treating diseases associated with pancreas.
    Type: Application
    Filed: February 13, 2008
    Publication date: September 11, 2008
    Applicant: APPLERA CORPORATION
    Inventors: Kim Alving, Steve Ruben, Ian McCaffery, Bruno Domon
  • Pancreatic cancer secreted targets and uses thereof
    Patent number: 7358231
    Abstract: The present invention provides a method for diagnosing and detecting diseases associated with pancreas. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in pancreatic diseases (PCAST) and antibodies binds to PCAST. The present invention provides that PCAST is used as targets for screening agents that modulates the PCAST activities. Further the present invention provides methods for treating diseases associated with pancreas.
    Type: Grant
    Filed: December 1, 2006
    Date of Patent: April 15, 2008
    Assignee: Applera Corporation
    Inventors: Ian McCaffey, Kim Alving, Bruno Domon, Steven Ruben